ArticleInternational journal of surgery (London, England)2026
Incidence trends and surgical outcomes of synchronous liver metastasis across cancer types: a population-based cohort study.
Article in International journal of surgery (London, England), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundLiver metastasis (LM) is commonly detected in a range of malignancies, but data on the incidence trends and efficacy of surgery are lacking. We aimed to assess incidence trends of synchronous LM in various primary cancers, and determine whether surgery is justified for such patients.
methodsThis retrospective population-based cohort study utilized data from 17 US registries of the Surveillance, Epidemiology, and End Results (SEER) program (2010-2021). Age-standardized incidence rates and annual percentage changes were used to character the incidence trends. Propensity score matching and multivariable Cox proportional hazards regression models were performed to examine the effect of LM surgery on overall survival (OS).
resultsAmong 4,180,870 cancer patients, 249,946 (6.0%) developed synchronous LM. The most common primary sites of LM were colorectum (25%), lung (24%), and pancreas (21%). The absolute number of LM patients increased between 2010-2021, with incidence increasing by 2.24% annually in 2010-2014, then decreasing by 0.69% annually until 2021. Notably, incidence of LM from colorectum, esophagus, and pancreas rose, whereas LM from lung and bronchus declined. Patients aged 60-79 were the major population suffering from LM, while significant increases were observed in those aged 20-39. Nearly 47.5% of LM cases were oligometastatic liver metastasis (oLM), indicating no metastasis to other organs. More than half of LM from small intestine, pancreas, colorectum, and stomach cancers were oligometastatic, whereas prostate, bone, and skin cancers developed multi-organ metastasis rapidly. Patients with oLM who underwent surgery of metastasis typically showed improved OS than those who did not (median OS, 6 months versus 44 months; 5-year survival rates, 7.4% versus 41%), especially for oLM from colorectum, pancreas, and small intestine cancers.
conclusionThe overall burden of LM increased between 2010 and 2021. There were significant differences in incidence trends, metastatic patterns, and surgical effectiveness of LM across various primary cancer types.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.